Stock-outs of malaria treatments at the health facility level in many sub-Saharan African countries have been a persistent problem for many years. A stock-out is the unavailability of medicine at the health facility. In Tanzania, 93 % of the population are at risk for malaria infection. The number of malaria cases is estimated to be 11 million resulting into 60-80 thousand deaths per year or 220 deaths per day in Tanzania alone. The goal of the SMS for Life pilot project was to develop a flexible and scalable solution to bring up-to-date visibility of anti-malarials within the Tanzanian Public Health Sector with a potential to reduce or eliminate stock-outs of five drugs (four dosage forms of ACTs and Quinine Injectable) in all health facilities in a pilot sample of three districts.
Initiated and led by Novartis, a public-private partnership was established with the Roll Back Malaria Partnership, IBM, Vodafone and the Ministry of Health in Tanzania. This unique partnership developed a solution using mobile phones, SMS messages, internet and mapping technology to visualize weekly stock inventory of Artemisinin Combination Therapy (ACTs) and Quinine Injectable at 129 health facilities and 226 villages. Over the course of one year, the Project Team designed the system, created a data repository, trained key staff and implemented the solution for a 21-week pilot in three districts of Tanzania: Ulanga, Kigoma Rural and Lindi Rural. These districts are located in three different regions and supplied from different Zonal Stores with a catchment population of 1.2 million people.
Stock-outs of malaria treatments at the health facility level in many sub-Saharan African countries have been a persistent problem for many years. A stock-out is the unavailability of medicine at the health facility. In Tanzania, 93 % of the population are at risk for malaria infection. The number of malaria cases is estimated to be 11 million resulting into 60-80 thousand deaths per year or 220 deaths per day in Tanzania alone. The goal of the SMS for Life pilot project was to develop a flexible and scalable solution to bring up-to-date visibility of anti-malarials within the Tanzanian Public Health Sector with a potential to reduce or eliminate stock-outs of five drugs (four dosage forms of ACTs and Quinine Injectable) in all health facilities in a pilot sample of three districts.
Initiated and led by Novartis, a public-private partnership was established with the Roll Back Malaria Partnership, IBM, Vodafone and the Ministry of Health in Tanzania. This unique partnership developed a solution using mobile phones, SMS messages, internet and mapping technology to visualize weekly stock inventory of Artemisinin Combination Therapy (ACTs) and Quinine Injectable at 129 health facilities and 226 villages. Over the course of one year, the Project Team designed the system, created a data repository, trained key staff and implemented the solution for a 21-week pilot in three districts of Tanzania: Ulanga, Kigoma Rural and Lindi Rural. These districts are located in three different regions and supplied from different Zonal Stores with a catchment population of 1.2 million people.
Post new comment